Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mangoceuticals Inc
MGRX
Healthcare
Medical Care
Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED...
) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MGRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(10)
•••
MikeTester
X
Post by
MikeTester
on Jan 24, 2025 2:17am
Mangoceuticals, Inc. (MGRX): A Diversified Player in the Men
Interesting play in men's health market. MGRX looks like a speculative bet with some potential. Revenues are tiny at $510k for 9 months in 2024 but they've got multiple product lines targeting
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 31, 2024 8:00am
New Press Release - Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Dallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced that the Company received a letter on...
read article.
Largest Integrated Facility Services Provider in Canada Releases Financial Results for Q1, 2025
posted May 11, 2025 9:00am by
GDI Integrated Facility Services Inc.
-
|
Adjusted EBITDA* amounted to $34 million, representing an Adjusted EBITDA* margin of 6% compared to $28 million and 4% in Q1 2024. Net income was $6 million or $0.26 per share compared to $0.4 million or $0.02 per share in Q1 2024.Long-term debt, net of cash* decreased by $14 million in the quarter ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 22, 2024 8:00am
New Press Release - MangoRx Announces Formation of Strategy and Alternatives Committee
Dallas, Texas, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced that its Board of Directors has...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 21, 2024 5:10pm
New Press Release - MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform learned earlier this morning that Eli Lilly has made...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 18, 2024 8:46am
New Press Release - Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024
Dallas, Texas--(Newsfile Corp. - October 18, 2024) - Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform,, is pleased to announce it will be presenting at the Centurion One Capital 2nd...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 11, 2024 5:15pm
New Press Release - MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss, and hormone...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 03, 2024 8:30am
New Press Release - MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, announces the release of its latest innovation, “TRIM,”...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 2:33pm
MGRX.....let's cut to the chase.....hurry up with the
P.O announcement Waiting patiently ; )
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 01, 2024 12:32pm
RE:MGRX....will this turn into a Gree to Red move
Green*......sheesh
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 12:31pm
MGRX....will this turn into a Gree to Red move
lots of resistance above and to 40 cents....next support is 20 cents Just my 2bits
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 11:52am
MGRX.....Well how do you like me so far?????
Re-read my last post Cheers !
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 01, 2024 8:24am
MGRX....Early a.m runner...but there is a reason ; )
Here is the fluff NR this a.m.....make sure you read my whole post ; ) MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
...more
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 12:03pm
Mangoceuticals, Inc. (MGRX): Navigating the Evolving MenR
https://beyondspx.com/2024/07/31/mangoceuticals-inc-mgrx-navigating-the-evolving-mens-wellness-landscape/
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 05, 2024 11:09am
MGRX....its official....just a P & D
No harm
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 05, 2024 8:56am
RE:MGRX...another ST pump
Was getting the tout by the Pumpers on StockTwits....last 2 weeks Nr this a.m Not for me but ...ya never know....48 cents
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >